insights_auto
Why is NVZMY up २.२२%?
Dive Deeperchevron_right
NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
US$ ६८.५९
arrow_upward
+२.२२%(+१.४९) 1D
अक्टोबर १५, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMY...
Open
US$ ६९.०५
High
US$ ६९.१५
Low
US$ ६८.४९
Mkt. cap
१.८३ खरब
Avg. vol.
२२.९८ हजार
Volume
२६.२० हजार
52-wk high
US$ ७५.२६
52-wk low
US$ ४९.९०
Beta
०.८७
Shares outstanding
४१.४६ करोड
No. of employees
११ हजार
Open
US$ ६९.०५
High
US$ ६९.१५
Low
US$ ६८.४९
Mkt. cap
१.८३ खरब
Avg. vol.
२२.९८ हजार
Volume
२६.२० हजार
52-wk high
US$ ७५.२६
52-wk low
US$ ४९.९०
Beta
०.८७
Shares outstanding
४१.४६ करोड
No. of employees
११ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
१२ घण्टा पहिले
Novonesis stock stands 1.27 percent below its 52-week high
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
CEOEster Baiget
Employees११.१ हजार
Founded२०००
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com